Low-intensity pulsed ultrasound

From WikiMD's WELLNESSPEDIA

Low-intensity pulsed ultrasound (LIPUS) is a medical therapy that uses pulses of ultrasound to stimulate the healing of fractures and other wounds. It is a non-invasive, painless, and safe treatment that has been used in clinical practice for over 30 years.

History[edit]

The use of ultrasound in medicine dates back to the 1940s, but it was not until the 1980s that researchers began to explore the potential of low-intensity pulsed ultrasound for promoting healing. The first clinical trials of LIPUS were conducted in the 1990s, and the therapy has been approved by the FDA for use in the United States since 1994.

Mechanism of action[edit]

LIPUS works by delivering low-intensity, pulsed ultrasound waves to the site of a fracture or wound. These waves stimulate the cells in the area, promoting the production of proteins and growth factors that are essential for healing. The exact mechanism by which LIPUS promotes healing is not fully understood, but it is believed to involve the stimulation of cell proliferation, angiogenesis, and osteogenesis.

Clinical applications[edit]

LIPUS is used in the treatment of a variety of conditions, including fractures, non-unions, delayed union, and osteoporosis. It is also used in the treatment of soft tissue injuries, such as ligament and tendon injuries, and in the management of chronic wounds.

Efficacy[edit]

Numerous studies have demonstrated the efficacy of LIPUS in promoting the healing of fractures and other wounds. However, the quality of the evidence is variable, and more high-quality, randomized controlled trials are needed to confirm these findings.

Safety[edit]

LIPUS is considered to be a safe treatment, with few reported side effects. However, as with any medical treatment, it should be used with caution in certain populations, such as those with pacemakers or other implanted electronic devices.

See also[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.